| __timestamp | Pharming Group N.V. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4167274 | 4050200000 |
| Thursday, January 1, 2015 | 5247851 | 5047100000 |
| Friday, January 1, 2016 | 4925118 | 6078400000 |
| Sunday, January 1, 2017 | 14930297 | 6931500000 |
| Monday, January 1, 2018 | 25371768 | 6861900000 |
| Tuesday, January 1, 2019 | 23921274 | 7056300000 |
| Wednesday, January 1, 2020 | 25338236 | 8149300000 |
| Friday, January 1, 2021 | 20182966 | 12310800000 |
| Saturday, January 1, 2022 | 17562000 | 9765700000 |
| Sunday, January 1, 2023 | 25212000 | 8988300000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, understanding cost structures is crucial. This analysis compares the cost of revenue for Viatris Inc. and Pharming Group N.V. from 2014 to 2023. Viatris Inc., a global healthcare giant, consistently reported higher costs, peaking in 2021 with a staggering 12.3 billion USD. In contrast, Pharming Group N.V., a smaller player, saw its highest cost in 2018, reaching 25.4 million USD. Over the decade, Viatris's costs were approximately 450 times higher than Pharming's, highlighting the scale difference. Interestingly, while Viatris's costs surged by 121% from 2014 to 2021, Pharming's costs grew by 506% in the same period, indicating rapid expansion. This data underscores the diverse financial strategies and market positions of these companies, offering insights into their operational efficiencies and growth trajectories.
Johnson & Johnson vs Viatris Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: AbbVie Inc. and Viatris Inc.
Analyzing Cost of Revenue: Vertex Pharmaceuticals Incorporated and Pharming Group N.V.
Cost of Revenue: Key Insights for Biogen Inc. and Viatris Inc.
United Therapeutics Corporation vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Viatris Inc. vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Viatris Inc. vs Dr. Reddy's Laboratories Limited
Comparing Cost of Revenue Efficiency: Viatris Inc. vs Corcept Therapeutics Incorporated
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down Pharming Group N.V. and Dyne Therapeutics, Inc.'s Expenses
Pharming Group N.V. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs BioCryst Pharmaceuticals, Inc.